351 related articles for article (PubMed ID: 28205554)
1. The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies.
Li Z; Ivanov AA; Su R; Gonzalez-Pecchi V; Qi Q; Liu S; Webber P; McMillan E; Rusnak L; Pham C; Chen X; Mo X; Revennaugh B; Zhou W; Marcus A; Harati S; Chen X; Johns MA; White MA; Moreno C; Cooper LA; Du Y; Khuri FR; Fu H
Nat Commun; 2017 Feb; 8():14356. PubMed ID: 28205554
[TBL] [Abstract][Full Text] [Related]
2. The OncoPPi Portal: an integrative resource to explore and prioritize protein-protein interactions for cancer target discovery.
Ivanov AA; Revennaugh B; Rusnak L; Gonzalez-Pecchi V; Mo X; Johns MA; Du Y; Cooper LAD; Moreno CS; Khuri FR; Fu H
Bioinformatics; 2018 Apr; 34(7):1183-1191. PubMed ID: 29186335
[TBL] [Abstract][Full Text] [Related]
3. OncoPPi-informed discovery of mitogen-activated protein kinase kinase 3 as a novel binding partner of c-Myc.
Ivanov AA; Gonzalez-Pecchi V; Khuri LF; Niu Q; Wang Y; Xu Y; Bai Y; Mo X; Prochownik EV; Johns MA; Du Y; Khuri FR; Fu H
Oncogene; 2017 Oct; 36(42):5852-5860. PubMed ID: 28628118
[TBL] [Abstract][Full Text] [Related]
4. Explore Protein-Protein Interactions for Cancer Target Discovery Using the OncoPPi Portal.
Ivanov AA
Methods Mol Biol; 2020; 2074():145-164. PubMed ID: 31583637
[TBL] [Abstract][Full Text] [Related]
5. Kinome-wide transcriptional profiling of uveal melanoma reveals new vulnerabilities to targeted therapeutics.
Bailey FP; Clarke K; Kalirai H; Kenyani J; Shahidipour H; Falciani F; Coulson JM; Sacco JJ; Coupland SE; Eyers PA
Pigment Cell Melanoma Res; 2018 Mar; 31(2):253-266. PubMed ID: 28972303
[TBL] [Abstract][Full Text] [Related]
6. Distinct and competitive regulatory patterns of tumor suppressor genes and oncogenes in ovarian cancer.
Zhao M; Sun J; Zhao Z
PLoS One; 2012; 7(8):e44175. PubMed ID: 22952919
[TBL] [Abstract][Full Text] [Related]
7. Network clusters analysis based on protein-protein interaction network constructed in phosgene-induced acute lung injury.
Liu Z; Gao F; Hou L; Qian Y; Tian R
Lung; 2013 Oct; 191(5):545-51. PubMed ID: 23963411
[TBL] [Abstract][Full Text] [Related]
8. Targeting protein-protein interactions as an anticancer strategy.
Ivanov AA; Khuri FR; Fu H
Trends Pharmacol Sci; 2013 Jul; 34(7):393-400. PubMed ID: 23725674
[TBL] [Abstract][Full Text] [Related]
9. Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway.
Li Z; Razavi P; Li Q; Toy W; Liu B; Ping C; Hsieh W; Sanchez-Vega F; Brown DN; Da Cruz Paula AF; Morris L; Selenica P; Eichenberger E; Shen R; Schultz N; Rosen N; Scaltriti M; Brogi E; Baselga J; Reis-Filho JS; Chandarlapaty S
Cancer Cell; 2018 Dec; 34(6):893-905.e8. PubMed ID: 30537512
[TBL] [Abstract][Full Text] [Related]
10. The histone methyltransferase Wolf-Hirschhorn syndrome candidate 1-like 1 (WHSC1L1) is involved in human carcinogenesis.
Kang D; Cho HS; Toyokawa G; Kogure M; Yamane Y; Iwai Y; Hayami S; Tsunoda T; Field HI; Matsuda K; Neal DE; Ponder BA; Maehara Y; Nakamura Y; Hamamoto R
Genes Chromosomes Cancer; 2013 Feb; 52(2):126-39. PubMed ID: 23011637
[TBL] [Abstract][Full Text] [Related]
11. Identification of Skt11-regulated genes in chondrocytes by integrated bioinformatics analysis.
Liang S; Zhang JM; Lv ZT; Cheng P; Zhu WT; Chen AM
Gene; 2018 Nov; 677():340-348. PubMed ID: 30107230
[TBL] [Abstract][Full Text] [Related]
12. A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.
Zhang J; Le TD; Liu L; He J; Li J
Gene; 2016 Feb; 577(1):55-64. PubMed ID: 26611531
[TBL] [Abstract][Full Text] [Related]
13. RN181 is a tumour suppressor in gastric cancer by regulation of the ERK/MAPK-cyclin D1/CDK4 pathway.
Wang S; Wang X; Gao Y; Peng Y; Dong N; Xie Q; Zhang X; Wu Y; Li M; Li JL
J Pathol; 2019 Jun; 248(2):204-216. PubMed ID: 30714150
[TBL] [Abstract][Full Text] [Related]
14. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
[TBL] [Abstract][Full Text] [Related]
16. The NSD3L histone methyltransferase regulates cell cycle and cell invasion in breast cancer cells.
Zhou Z; Thomsen R; Kahns S; Nielsen AL
Biochem Biophys Res Commun; 2010 Jul; 398(3):565-70. PubMed ID: 20599755
[TBL] [Abstract][Full Text] [Related]
17. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
[TBL] [Abstract][Full Text] [Related]
18. Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma.
Singh AR; Joshi S; Burgoyne AM; Sicklick JK; Ikeda S; Kono Y; Garlich JR; Morales GA; Durden DL
Mol Cancer Ther; 2016 Nov; 15(11):2553-2562. PubMed ID: 27496136
[TBL] [Abstract][Full Text] [Related]
19. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
20. NSD3-Induced Methylation of H3K36 Activates NOTCH Signaling to Drive Breast Tumor Initiation and Metastatic Progression.
Jeong GY; Park MK; Choi HJ; An HW; Park YU; Choi HJ; Park J; Kim HY; Son T; Lee H; Min KW; Oh YH; Lee JY; Kong G
Cancer Res; 2021 Jan; 81(1):77-90. PubMed ID: 32967925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
